Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.
Petruk G, Puthia M, Samsudin F, Petrlova J, Olm F, Mittendorfer M, Hyllén S, Edström D, Strömdahl AC, Diehl C, Ekström S, Walse B, Kjellström S, Bond PJ, Lindstedt S, Schmidtchen A.
Petruk G, et al.
Nat Commun. 2023 Sep 29;14(1):6097. doi: 10.1038/s41467-023-41702-y.
Nat Commun. 2023.
PMID: 37773180
Free PMC article.